Rapid AST technology deployment across the rapid antimicrobial susceptibility testing market spans several distinct approaches, each requiring its own combination of instruments, consumables and software. The technology type a laboratory adopts, whether phenotypic, genotypic, microfluidics-based or AI-enhanced, largely determines which instruments, reagent panels and software platforms it must acq
View Detail